This HTML5 document contains 36 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n7http://linked.opendata.cz/resource/drugbank/drug/DB07700/identifier/pubchem-compound/
n8http://linked.opendata.cz/resource/drugbank/drug/DB07700/identifier/pubchem-substance/
n11http://linked.opendata.cz/resource/drugbank/drug/DB07700/identifier/drugbank/
n10http://bio2rdf.org/drugbank:
admshttp://www.w3.org/ns/adms#
n6http://linked.opendata.cz/resource/drugbank/drug/DB07700/identifier/chemspider/
n13http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
owlhttp://www.w3.org/2002/07/owl#
n3http://linked.opendata.cz/ontology/drugbank/
n4http://linked.opendata.cz/resource/drugbank/property/
xsdhhttp://www.w3.org/2001/XMLSchema#
n12http://linked.opendata.cz/resource/drugbank/drug/DB07700/identifier/pdb/

Statements

Subject Item
n2:DB07700
rdf:type
n3:Drug
n3:group
experimental
owl:sameAs
n10:DB07700 n13:DB07700
dcterms:title
3-CARBOXAMIDO-1,3,5(10)-ESTRATRIEN-17(R)-SPIRO-2'(5',5'-DIMETHYL-6'OXO)TETRAHYDROPYRAN
adms:identifier
n6:10160279 n7:11987804 n8:99444171 n11:DB07700 n12:E04
n3:IUPAC-Name
n4:271B5DEB-363D-11E5-9242-09173F13E4C5
n3:InChI
n4:271B5DF1-363D-11E5-9242-09173F13E4C5
n3:Molecular-Formula
n4:271B5DF0-363D-11E5-9242-09173F13E4C5
n3:Molecular-Weight
n4:271B5DED-363D-11E5-9242-09173F13E4C5
n3:Monoisotopic-Weight
n4:271B5DEE-363D-11E5-9242-09173F13E4C5
n3:SMILES
n4:271B5DEF-363D-11E5-9242-09173F13E4C5
n3:Water-Solubility
n4:271B5DE9-363D-11E5-9242-09173F13E4C5
n3:logP
n4:271B5DEA-363D-11E5-9242-09173F13E4C5 n4:271B5DE7-363D-11E5-9242-09173F13E4C5
n3:logS
n4:271B5DE8-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Acceptor-Count
n4:271B5DF7-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Donor-Count
n4:271B5DF8-363D-11E5-9242-09173F13E4C5
n3:InChIKey
n4:271B5DF2-363D-11E5-9242-09173F13E4C5
n3:Polar-Surface-Area--PSA-
n4:271B5DF3-363D-11E5-9242-09173F13E4C5
n3:Polarizability
n4:271B5DF5-363D-11E5-9242-09173F13E4C5
n3:Refractivity
n4:271B5DF4-363D-11E5-9242-09173F13E4C5
n3:Rotatable-Bond-Count
n4:271B5DF6-363D-11E5-9242-09173F13E4C5
n3:Bioavailability
n4:271B5DFD-363D-11E5-9242-09173F13E4C5
n3:Ghose-Filter
n4:271B5DFF-363D-11E5-9242-09173F13E4C5
n3:MDDR-Like-Rule
n4:271B5E00-363D-11E5-9242-09173F13E4C5
n3:Number-of-Rings
n4:271B5DFC-363D-11E5-9242-09173F13E4C5
n3:Physiological-Charge
n4:271B5DFB-363D-11E5-9242-09173F13E4C5
n3:Rule-of-Five
n4:271B5DFE-363D-11E5-9242-09173F13E4C5
n3:Traditional-IUPAC-Name
n4:271B5DEC-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-acidic-
n4:271B5DF9-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-basic-
n4:271B5DFA-363D-11E5-9242-09173F13E4C5